Literature DB >> 21984636

[Acute mesenteric ischemia].

J-P Ritz1, H J Buhr.   

Abstract

Acute mesenteric ischemia (AMI) is a rare cause of acute abdomen. Coupled with a high patient age, non-specific clinical symptoms and a significant co-morbidity the disease is still associated with a significant mortality of 60-85%. With a combination of preexisting cardiac arrhythmia and sudden abdominal pain AMI should always first be ruled out. Contrast-enhanced computed tomography (CT) scanning has replaced angiography as the first diagnostic step, largely because both intravascular and intra-abdominal pathologies can be diagnosed. In the case of an acute abdomen or lack of immediate access to diagnostic tools, rapid surgical exploration should be preferred. Surgical therapy includes embolectomy and resection of ischemic bowel segments. There should be a wide indication for second-look surgery. The most important prognostic factor and the only factor that can be influenced by the surgeon is the time interval between onset of symptoms and surgery. Therefore angiography or laparotomy should be performed as early as possible in cases of suspected AMI.

Entities:  

Mesh:

Year:  2011        PMID: 21984636     DOI: 10.1007/s00104-011-2098-4

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  28 in total

Review 1.  Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences.

Authors:  Brigitte Vollmar; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2010-11-19       Impact factor: 3.445

2.  [Indications and results of second-look operation in acute mesenteric vascular occlusion].

Authors:  H Denecke; H Stiegler
Journal:  Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir       Date:  1990

Review 3.  [Surgical technical guidelines in intestinal ischemia].

Authors:  M Betzler
Journal:  Chirurg       Date:  1998-01       Impact factor: 0.955

Review 4.  Indications and procedures for second-look surgery in acute mesenteric ischemia.

Authors:  Xianzhi Meng; Lianxin Liu; Hongchi Jiang
Journal:  Surg Today       Date:  2010-07-30       Impact factor: 2.549

Review 5.  An aggressive roentgenologic and surgical approach to acute mesenteric ischemia.

Authors:  S J Boley; S Sprayregen; F J Veith; S S Siegelman
Journal:  Surg Annu       Date:  1973

Review 6.  Intestinal blood flow.

Authors:  D N Granger; P D Richardson; P R Kvietys; N A Mortillaro
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

7.  Laparoscopic diagnostics of acute bowel ischemia using ultraviolet light and fluorescein dye: an experimental study.

Authors:  Jiri Paral; Paral Jiri; Alexander Ferko; Ferko Alexander; Michal Plodr; Plodr Michal; Jan Raupach; Raupach Jan; Dimitar Hadzi-Nikolov; Hadzi-Nikolov Dimitar; David Dolezal; Dolezal David; Vendelin Chovanec; Chovanec Vendelin
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2007-08       Impact factor: 1.719

Review 8.  Thrombolytic therapy for acute superior mesenteric artery occlusion.

Authors:  Ivo G Schoots; Marcel M Levi; Jim A Reekers; Johan S Lameris; Thomas M van Gulik
Journal:  J Vasc Interv Radiol       Date:  2005-03       Impact factor: 3.464

9.  [Mesenterial infarct. New aspects of diagnosis and therapy].

Authors:  E Paes; J F Vollmar; S Hutschenreiter; M H Schoenberg; R Kübel; E Schölzel
Journal:  Chirurg       Date:  1988-12       Impact factor: 0.955

10.  Unchanged high mortality rates from acute occlusive intestinal ischemia: six year review.

Authors:  Woubet T Kassahun; Thomas Schulz; Olaf Richter; Johann Hauss
Journal:  Langenbecks Arch Surg       Date:  2008-01-03       Impact factor: 3.445

View more
  2 in total

1.  [The role of biomarkers in the diagnostics of acute mesenteric ischemia].

Authors:  M Reichert; M Hecker; R Hörbelt; S Lerner; J Höller; C M Hecker; W Padberg; M A Weigand; A Hecker
Journal:  Chirurg       Date:  2015-01       Impact factor: 0.955

Review 2.  [Acute mesenteric ischemia].

Authors:  M Scheurlen
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-09-11       Impact factor: 0.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.